American Journal of Transplantation Journal
Overview
Publication venue for
- Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis 2022
- Inferior Vena Caval Complications Following Orthotopic Liver Transplant. 22:28-28. 2021
- White paper on antimicrobial stewardship in solid organ transplant recipients 2021
- Albumin Level Prior to Liver-Directed Therapy is a Risk Factor of Waitlist Tumor Progression Independent of HCC Burden. 21:770-771. 2021
- Assessing the Impact of the New Liver Allocation Policy on Transplant Center and Organ Procurement Organization Logistics. 21:788-788. 2021
- Influence of Induction Therapy and Antiretroviral Regimen on Outcomes in HIV Positive Renal Transplant Recipients. 21:369-369. 2021
- Observational Study of the Clinical Characteristics and Shortterm Outcomes of Kidney Transplant Recipients Diagnosed with Coronavirus-19 Infection (sars-cov2) Requiring Hospitalization in New Orleans. 21:608-608. 2021
- Quantifying the Interaction Between Posaconazole and Tacrolimus in Liver Transplant Recipients: A Practical Approach. 21:760-760. 2021
- Assessment Of Hepatic Macrosteatosis Using A Convolutional Deep Neural Network. 20:38-38. 2020
- Biomarkers AFP in Combination with AFP-l3 and DCP Predicts Tumor Progression in Treatment Native HCC Patients. 20:492-493. 2020
- Cirrhosis-Driven Immune Dysfunction is Associated with Poor Response to DEB-TACE and Waitlist Dropout in Hepatocellular Carcinoma Patients While Awaiting Liver Transplantation. 20:492-492. 2020
- Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. 20:617-619. 2020
- Donor and Recipient Flow Crossmatch Positivity is Associated with Increased Risk of Acute Rejection in Simultaneous Liver-Kidney Transplantations. 20:60-60. 2020
- Effects of Donor Macrosteatosis and Post-Transplant Complement Activation on Early Allograft Dysfunction. 20:60-60. 2020
- Expansion of Immunosuppressive Cell Populations Associates with Tumor-Derived Exosome Shedding in Early-Stage HCC Patients undergoing Locoregional Therapy. 20:60-60. 2020
- High PRA Increases Rejection but Does Not Worsen Renal Function in the First Year Post Kidney Transplant with Alemtuzumab Induction. 20:912-912. 2020
- Increased utilization of liver donors with infectious labels after implementation of a focused education program. 20:38-39. 2020
- Safety Outcomes in Lower-Weight vs Higher-Weight Recipients of Fixed Dose Alemtuzumab for Kidney Transplant Induction. 20:904-905. 2020
- Utilization of Hepatitis C Positive Organs in Kidney Transplantation. 20:881-882. 2020
- Comparable Outcomes of Deceased Donor Liver Transplant Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis.. 19:713-714. 2019
- Comparable Outcomes of Deceased Donor Liver Transplants (DDLT) Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre-Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis. 19:36-36. 2019
- Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naive Hepatocellular Carinoma Patients.. 19:767-767. 2019
- Impact of Previous Abdominal Surgeries in Deceased Liver Transplantation. 19:37-37. 2019
- Modified BALAD Score Predicts Incomplete Locoregional Therapy Treatment in Hepatocellular Carcinoma Patients. 19:72-73. 2019
- Patterns and Predictors of Alcohol Use after Early Liver Transplant for Alcoholic Hepatitis.. 19:561-562. 2019
- Perceptions and Attitude of Transplant Clinicians towards Antimicrobial Resistance and Stewardship in Transplant Recipients: A Survey of the American Society Transplantation.. 19:737-737. 2019
- Pre-Treatment Lymphocyte Status in HCC Patients Associates with DEB-TACE Response and Correlates with Increased Regulatory Immune Cells.. 19:762-762. 2019
- Rabbit Anti-Thytnocyte Globulin (rATG) Induction in Heart Transplant Recipients at High Risk for Rejection.. 19:784-785. 2019
- Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients.. 19:461-462. 2019
- Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant.. 19:820-820. 2019
- Synthetic Liver Function and Absolute Lymphocyte Count in HCC Patients is Associated with Poor Tumor Response to Locoregional Therapy and Increases in Immunosuppressive Cell Populations. 19:73-73. 2019
- The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults.. 19:418-418. 2019
- Use of HCV Positive Livers in HCV Negative Recipients: The Ochsner Experience. 19:70-70. 2019
- Using 3D Printed Smartphone-Microscope Adapter Tool to Improve Donor Liver Biopsy Evaluation. 19:62-63. 2019
- Adipokines Alter Immune Surveillance & Promote an Aggressive HCC Phenotype. 18:74-74. 2018
- End Stage Renal Disease after Face Transplant.. 18:358-358. 2018
- Endovascular Management of Hepatic Artery Stenosis: Risk Factors and Outcomes. 18:67-68. 2018
- Impact of On-Site Overestimation of Macrosteatosis on Donor Liver Biopsy.. 18:573-573. 2018
- Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes.. 18:573-574. 2018
- Long-Term Effects of Ketoconazole in Rapid Tacrolimus Metabolizers Post-Renal Transplantation.. 18:797-797. 2018
- Lymphopenia in Waitlist Treatment Naive HCC Patients is Associated with Myeloid-Derived Suppressor Cell Expansion and Poor Tumor Response to Doxorubicin-Eluting Bead Transarterial Chemoembolization. 18:85-85. 2018
- Outcomes in Liver and Combined Liver-Kidney Retransplantation.. 18:342-342. 2018
- Outcomes of Livers Allocated to High UNOS Match Sequence Number Recipients at a High Volume Transplant Center.. 18:568-568. 2018
- Portal Vein Thrombosis (PVT) in Liver Transplantation - Recent Experience.. 18:556-557. 2018
- Pre Liver Transplant (LT) Prediction of Surgical Complexity by Recipient Risk Grading and Optimizing Outcomes: The Ochsner Experience.. 18:848-849. 2018
- T Cell Lineage Imbalance and Regulatory Immune Populations in HCC Patients Undergoing Downstaging While Waitlisted for Liver Transplantation.. 18:722-722. 2018
- Effect of Embolization History and Tumor Treatment Response on Plasma TGF beta in HCC Patients Listed for Liver Transplantation. 17:433-433. 2017
- Pre-TACE Immune Status Correlates with Treatment Response and Tumor Biology in HCC as a Bridge to Transplant. 17:436-436. 2017
- Predicting Recurrence Prior to Transplant: The Response of HCC to Chemoembolization. 17:436-437. 2017
- Results of High Risk Donation-after-Circulatory Death (DCD) Donor Liver Transplants. 17:19-19. 2017
- Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy. 17:2155-2164. 2017
- SiLK: Single Incision Approach for Combined Liver Kidney Transplantation. 17:75-75. 2017
- US Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH). 17:407-407. 2017
- Donor-Recipient Matching in Deceased Donor Liver Transplantation: Analysis of Outcomes Using UNOS Match Sequence Data. 16:77-77. 2016
- Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.. 16:461-462. 2016
- Outcomes of DCD Liver Transplantation Utilizing Donors With High Donor Risk Index. 16:83-83. 2016
- Results from 100 Consecutive Donation-After-Circulatory Death (DCD) Liver Transplants Using a Thrombolytic Protocol.. 16:584-584. 2016
- Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.. 16:793-794. 2016
- Short Duration Perioperative Administration of Ledipasvir/Sofosbuvir Is Safe and Effective in Preventing HCV Recurrence After Liver Transplant.. 16:333-334. 2016
- Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.. 16:593-593. 2016
- Transcatheter Aortic Valve Replacement (TAVR) for Severe Aortic Stenosis as a Bridge to Liver Transplantation.. 16:676-676. 2016
- Utilizing Imported Liver Grafts for HCC Recipients. 16:82-82. 2016
- Vaccination Compliance in Listed Kidney Transplant Candidates: A Retrospective Chart Review.. 16:731-731. 2016
- Calciphylaxis in Simultaneous Liver-Kidney Transplantation. 15:1105-1109. 2015
- Expanding the Donor Pool: Comparison of Outcomes in DCD vs. Living Donor Liver Transplantation. 15:93-93. 2015
- Is BMI of 28 an Appropriate Cutoff for Simultaneous Pancreas Kidney Transplant in Type II Diabetes?. 15. 2015
- Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience. 15. 2015
- Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation. 15. 2015
- Outpatient Management of Intra-Corporeal Left Ventricular Assist Device System in Children: A Multi-Center Experience. 15:453-460. 2015
- Post-Liver Transplant Delirium Is Associated With Increased Mortality and Prolonged Length of Stay. 15. 2015
- Three Year Outcomes of Renal Allograft Transplants in African American Recipients Receiving Alemtuzumab for Induction Immunosuppression. 15. 2015
- DCD Procurements: Low Incidence of Ischemic Cholangiopathy and Improving Outcomes in Liver Transplantation (LT) from Donation after Circulatory Death (DCD). 14:56-57. 2014
- Improving Outcomes in Liver Transplantation from Donation after Circulatory Death. 14:95-95. 2014
- Role of Special Coagulation Studies for Pre-Operative Screening in Simultaneous Kidney-Pancreas Transplantation. 14:863-863. 2014
- Thrombolytic Protocol Minimizes Ischemic-type Biliary Complications in Liver Transplantation from Donation-After-Cardiac Death Donors. 14:65-65. 2014
- Type 2 Diabetes Mellitus Recipients Achieved Excellent Outcomes in Simultaneous Kidney-Pancreas Transplantation Despite High Post-Operative Weight Gain.. 14:857-858. 2014
- Benefits of a Robotic Donor Nephrectomy Program: A Series of 100 Consecutive Donors.. 13:392-392. 2013
- Liver Transplantation (OLT) Utilizing Donation after Cardiac Death (DCD) Allografts: A Single Center Experience. 13:87-87. 2013
- Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial. 12:3021-3030. 2012
- Excellent Outcomes after Liver Retransplantation for Recurrent HCV: A Single Centre Experience. 12:432-432. 2012
- Late Liver Retransplantation: A Single Center Experience. 12:86-86. 2012
- Peer Review, Performance Improvement and the UNOS Membership and Professional Standards Committee: One Center's Experience. 12:87-87. 2012
- Anti-HBc Positive Donor Livers in Naive Hepatitis B Recipients: 10 Years Experience in a Single Center. 11:202-202. 2011
- Lessons Learned from the Introduction of a Robotic Assisted Donor Nephrectomy Program. 11:73-73. 2011
- Incidence of delayed kidney allograft function in combined heart and kidney transplantation compared with kidney transplant alone, based on OPTN (Organ procurement and transplantation network) data as of December 2006.. 8:347-347. 2008
Identity
International Standard Serial Number (ISSN)
- 1600-6135